Skip to main content
LYEL logo

LYEL · Lyell Immunopharma, Inc.

$12.78 -0.06 (-0.47%) At close · Jul 23
Market Cap
$298.21M
Shares
23.33M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 74
Total Value: $240,098,462
Total Shares: 11,970,374

Institutional Ownership Trend

5 quarters

Holder Concentration

Across 74 13F filers
Top Holder
27.1%
Jun 2025 → Mar 2026 · range 24.1% – 28.5%
of institutional value
Top 5
58.8%
Jun 2025 → Mar 2026 · range 58.8% – 63.1%
of institutional value
Top 10
77.5%
Jun 2025 → Mar 2026 · range 77.5% – 85.6%
of institutional value
HHI
1,116
Jun 2025 → Mar 2026 · range 1,060 – 1,238
Broadly held
Showing 75 of 75
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1806952 CUSIP 55083R203 13F (30d) 3 filings 3 filers Visit website Investor relations